AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Lagosita M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Max pharma

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Lagosita M 50mg/500mg Tablet

Diabex Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like vision impairment and kidney disease, potentially lowering the risk of stroke or heart attack. Diabex Duo may be used alone or with other diabetes treatments, and works optimally alongside a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and current medications. Consuming it with food minimizes stomach upset. For maximum effectiveness, take it consistently at the same time daily; discontinue only under your physician's guidance. Adhering to your doctor's recommended diet and exercise plan is crucial for optimal diabetes management; lifestyle choices significantly impact control. Common side effects include nausea, diarrhea, vomiting, stomach discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is possible, especially if you're also using insulin or sulfonylureas; learn how to identify and treat this. This medication isn't for everyone. Inform your doctor about any pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption before starting. Pregnant or nursing individuals should seek medical advice. Inform your doctor of all other medications you take to ensure compatibility and safety. Alcohol should be minimized due to its blood sugar-lowering effect. Your doctor will monitor your kidney function and blood glucose levels throughout treatment.

Uses of Lagosita M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Lagosita M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Lagosita M 50mg/500mg Tablet whole; do not crush, chew, or break it. Administer this medication with a meal.

Common Side effects of Lagosita M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Lagosita M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Lagosita M 50mg/500mg Tablets. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

How Lagosita M 50mg/500mg Tablet works:

Lagosita M 50mg/500mg tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Lagosita M 50mg/500mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Lagosita M 50mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Nursing mothers should likely avoid Lagosita M 50mg/500mg Tablets. Preliminary data in humans indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

For individuals with kidney impairment, Lagosita M 50mg/500mg tablets require careful administration, potentially necessitating dosage modification. Physician consultation is recommended. In cases of severe kidney disease, Lagosita M 50mg/500mg tablets are contraindicated. Routine monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

The use of Lagosita M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Seek medical advice before taking this medication.

What if you forget to take Lagosita M 50mg/500mg Tablet :

Should you forget to take your Lagosita M 50mg/500mg Tablet, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Lagosita M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Treatment

FAQs on Lagosita M 50mg/500mg Tablet

Lagosita M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Prolonged use of Lagosita M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, potentially affecting mental function. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Lagosita M 50mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Lagosita M 50mg/500mg Tablets are contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Lagosita M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Lagosita M 50mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excess blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Lagosita M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Lagosita M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Lagosita M 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Lagosita M 50mg/500mg tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Lagosita M 50mg/500mg Tablet. This rare complication is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol, hence its avoidance in these groups. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Lagosita M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Lagosita M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Lagosita M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Lagosita M 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Lagosita M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lagosita M 50mg/500mg Tablets can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Lagosita M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and balance problems), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it remains inaccessible to children, pets, and others.
Lagosita M 50mg/500mg Tab...
259
MRP 300
13% off